hold on to your money folks. we're taking a dip in the pool

New Post Public Reply Private Reply Replies (1) Message Board
joey68
129
hold on to your money folks. we're taking a dip in the pool for a bit. may be able to squeak out an extra couple hundred shares here per dollar we spend.

Iconic Brands, Inc. (ICNB) Stock Research Links

ICNB Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Partnership Between Philips and Masimo Enhances Care

Updated Category News Views 184

New Collaboration Between Philips and Masimo In a significant development in the healthcare technology sector, Royal Philips and Masimo have announced an exciting renewal of their collaboration. This renewed partnership reflects the ongoing commitment of both companies towards innovation and improving the experiences of patients and healthcare providers alike. Advancing...

Continue Reading
Exploring Cava Group's Recent Bullish Options Activity

Updated Category News Views 102

Cava Group's Unusual Options Activity Overview Investors looking to capitalize on market trends have adopted a bullish outlook on Cava Group (CAVA). This significant move is invaluable information for retail traders. Today, we observed noteworthy activity in the options market which has been reported on various trading platforms. Such trades suggest that knowledgeable...

Continue Reading
MDU Resources Group Declares Consistent Quarterly Dividend

Updated Category News Views 139

MDU Resources Announces Quarterly Dividend Update Today, MDU Resources Group, Inc. (NYSE: MDU) has declared a quarterly dividend of 13 cents per share on its common stock, continuing its commitment to return value to its shareholders. This dividend remains unchanged from the previous quarter, reflecting the company’s stable financial position and its confidence in...

Continue Reading
JCDecaux's Q3 2024 Review: Strong Digital Growth & Future Prospects

Updated Category News Views 140

JCDecaux's Q3 2024 Business Insights On November 7, JCDecaux SE (Euronext Paris: DEC), recognized as the leading outdoor advertising firm globally, released its comprehensive report for Q3 2024, highlighting developments up to September 30, 2024. Year-Over-Year Performance During this quarter, JCDecaux reported a remarkable revenue increase of 10.9%, reaching a total of...

Continue Reading
Zealand Pharma Strengthens Presence with Roche Collaboration

Updated Category News Views 178

Exciting Collaboration Between Zealand Pharma and Roche Zealand Pharma A/S has reached a significant milestone by finalizing its collaboration and license agreement with Roche, a move widely anticipated in the biotechnology sector. The partnership marks a turning point in Zealand Pharma's mission to be a leader in innovative peptide-based therapies, especially in the...

Continue Reading